Vertex Pharmaceuticals market cap VRTX

Share price times shares outstanding: what the whole company sells for, since 2010.

Vertex Pharmaceuticals is worth $132.8B at the close on Oct 23, 2026, at $523.93 a share.

That is up 23% over the last year and up 177% over five years.

Its highest close in our data was $138.9B in Aug 2026.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$132.8B	$107.7B	$138.9B	+13%
2025	$117.4B	$94B	$129.6B	+12%
2024	$105.3B	$101.8B	$133.1B	+0%
2023	$104.8B	$73.8B	$105.8B	+41%
2022	$74.1B	$56.4B	$82.5B	+33%
2021	$55.8B	$46.4B	$61.8B	−9%
2020	$61.5B	$53.4B	$76.4B	+8%
2019	$56.8B	$42.6B	$57.4B	+38%
2018	$41.3B	$38.1B	$49.3B	+9%
2017	$37.9B	$19.7B	$40.9B	+107%
2016	$18.3B	$18.3B	$27.2B	−41%
2015	$30.9B	$25.3B	$33.7B	+9%
2014	$28.5B	$14.9B	$28.6B	+66%
2013	$17.2B	$9.9B	$19.6B	+93%
2012	$8.9B	$7.1B	$13.7B	+28%
2011	$6.9B	$5.5B	$11.8B	−3%
2010	$7.1B	$6.5B	$7.8B	n/a

Companies in Biotechnology nearest Vertex Pharmaceuticals' size, closest first, today.

Company	Market cap
VRTXVertex Pharmaceuticals	$132.8B
REGNRegeneron Pharmaceuticals	$82.9B
ONCBeOne Medicines	$42.9B
ALNYAlnylam Pharmaceuticals	$30B
UTHRUnited Therapeutics	$25.2B
INCYIncyte	$23.5B
EXELExelixis	$16B
NBIXNeurocrine Biosciences	$14.5B
HALOHalozyme Therapeutics	$14.3B
Peer median	$24.3B